logo
logo

Madrigal Pharmaceuticals Appoints Bill Sibold As Chief Executive Officer My Ches Co

Madrigal Pharmaceuticals Appoints Bill Sibold As Chief Executive Officer My Ches Co

09/14/23, 9:22 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgconshohocken
Industry
biotechnology
health care
Position
chief executive officer
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. this week announced that Bill Sibold has succeeded Paul Friedman, M.D., as Chief Executive Officer and joined Madrigal’s Board of Directors. Dr

Company Info

Company
Madrigal
Location
conshohocken, pennsylvania, united states
Additional Info
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), a liver disease with high unmet medical need. Madrigal’s lead candidate, resmetirom, is a once daily, oral, thyroid hormone receptor (THR)-β selective agonist that is designed to target key underlying causes of NASH in the liver. Resmetirom is currently being evaluated in two Phase 3 clinical studies, MAESTRO-NASH and MAESTRO-NAFLD-1, designed to demonstrate multiple benefits in patients with NASH.

Related People